These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38864982)

  • 21. Patterns of Early Coronary Artery Changes in Pediatric Heart Transplant Recipients Detected Using Optical Coherence Tomography.
    Laguë SL; Bone JN; Samuel R; Voss C; Balbacid E; Hosking MCK; Schubert S; Harris KC
    Circ Cardiovasc Imaging; 2022 Jan; 15(1):e012486. PubMed ID: 35041446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optical coherence tomography for the evaluation of asymmetric cardiac allograft vasculopathy in a child.
    Greenway SC; Hosking M; Harris KC
    Pediatr Transplant; 2014 Sep; 18(6):E190-2. PubMed ID: 24953969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of intravascular ultrasound in the assessment of coronary allograft vasculopathy: a review.
    Logani S; Saltzman HE; Kurnik P; Eisen HJ; Ledley GS
    J Interv Cardiol; 2011 Feb; 24(1):9-14. PubMed ID: 21029179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implications of intracoronary imaging in cardiac allograft vasculopathy.
    Guddeti RR; Matsuo Y; Matsuzawa Y; Aoki T; Lerman LO; Kushwaha SS; Lerman A
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25596140
    [No Abstract]   [Full Text] [Related]  

  • 25. Invasive Intracoronary Imaging of Cardiac Allograft Vasculopathy: Established Modalities and Emerging Technologies.
    Shahandeh N; Parikh RV
    Interv Cardiol Clin; 2023 Apr; 12(2):269-280. PubMed ID: 36922067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.
    Okada K; Fearon WF; Luikart H; Kitahara H; Otagiri K; Tanaka S; Kimura T; Yock PG; Fitzgerald PJ; Yeung AC; Valantine HA; Khush KK; Honda Y
    J Am Coll Cardiol; 2016 Jul; 68(4):382-92. PubMed ID: 27443435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early detection of cardiac allograft vasculopathy using highly automated 3-dimensional optical coherence tomography analysis.
    Pazdernik M; Chen Z; Bedanova H; Kautzner J; Melenovsky V; Karmazin V; Malek I; Tomasek A; Ozabalova E; Krejci J; Franekova J; Wahle A; Zhang H; Kovarnik T; Sonka M
    J Heart Lung Transplant; 2018 Aug; 37(8):992-1000. PubMed ID: 29706574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound.
    Jang IK; Bouma BE; Kang DH; Park SJ; Park SW; Seung KB; Choi KB; Shishkov M; Schlendorf K; Pomerantsev E; Houser SL; Aretz HT; Tearney GJ
    J Am Coll Cardiol; 2002 Feb; 39(4):604-9. PubMed ID: 11849858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optical Coherence Tomography in Cardiac Allograft Vasculopathy: State-of-the-Art Review.
    Acharya D; Loyaga-Rendon RY; Chatterjee A; Rajapreyar I; Lee K
    Circ Heart Fail; 2021 Sep; 14(9):e008416. PubMed ID: 34414769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiological evaluations of initial plaque development after heart transplantation via serial multimodality imaging and cytokine assessments.
    Shiraki T; Ichibori Y; Ohtani T; Mizote I; Kioka H; Tsukamoto Y; Nakamura D; Yokoi K; Ide S; Nakamoto K; Takeda Y; Kotani JI; Hikoso S; Sawa Y; Sakata Y
    J Heart Lung Transplant; 2022 Jul; 41(7):877-885. PubMed ID: 35400587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue characterization of progressive cardiac allograft vasculopathy in patients with everolimus therapy compared with donor-transmitted atherosclerosis assessed using serial intravascular imaging: a case report.
    Watanabe T; Kotani J; Murata Y; Seguchi O; Yanase M; Nakatani T
    Transplant Proc; 2014 Sep; 46(7):2456-61. PubMed ID: 25242801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV study).
    Khandhar SJ; Yamamoto H; Teuteberg JJ; Shullo MA; Bezerra HG; Costa MA; Selzer F; Lee JS; Marroquin OC; McNamara DM; Mulukutla SR; Toma C
    J Heart Lung Transplant; 2013 Jun; 32(6):596-602. PubMed ID: 23499356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylsalicylic acid use and development of cardiac allograft vasculopathy: A national prospective study using highly automated 3-D optical coherence tomography analysis.
    Mayerova L; Wohlfahrt P; Sonka M; Chen Z; Kautzner J; Melenovsky V; Karmazin V; Malek I; Bedanova H; Tomasek A; Ozabalova E; Krejci J; Kovarnik T; Pazdernik M
    Clin Transplant; 2024 Mar; 38(3):e15275. PubMed ID: 38477134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac PET Myocardial Blood Flow Quantification Assessment of Early Cardiac Allograft Vasculopathy.
    Chih S; Tavoosi A; Nair V; Chong AY; Džavík V; Aleksova N; So DY; deKemp RA; Amara I; Wells GA; Bernick J; Overgaard CB; Celiker-Guler E; Mielniczuk LM; Stadnick E; McGuinty C; Ross HJ; Beanlands RSB
    JACC Cardiovasc Imaging; 2024 Jun; 17(6):642-655. PubMed ID: 37999656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravascular ultrasound-guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients.
    Nelson LM; Rossing K; Ihlemann N; Boesgaard S; Engstrøm T; Gustafsson F
    Clin Transplant; 2020 Dec; 34(12):e14124. PubMed ID: 33068292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy.
    Foldyna B; Sandri M; Luecke C; Garbade J; Gohmann R; Hahn J; Fischer J; Gutberlet M; Lehmkuhl L
    Eur Radiol; 2020 Aug; 30(8):4317-4326. PubMed ID: 32179995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravascular ultrasound of the proximal left anterior descending artery is sufficient to detect early cardiac allograft vasculopathy.
    Floré V; Brown AJ; Pettit SJ; West NEJ; Lewis C; Parameshwar J; Hoole SP
    Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29194769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy".
    Pighi M; Gratta A; Marin F; Bellamoli M; Lunardi M; Fezzi S; Zivelonghi C; Pesarini G; Tomai F; Ribichini F
    Transplant Rev (Orlando); 2020 Oct; 34(4):100569. PubMed ID: 32739137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OCT assessment of allograft vasculopathy in heart transplant recipients.
    Hou J; Lv H; Jia H; Zhang S; Xing L; Liu H; Kong J; Zhang S; Yu B; Jang IK
    JACC Cardiovasc Imaging; 2012 Jun; 5(6):662-3. PubMed ID: 22698538
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.